Update on the prevention and treatment of endophthalmitis

Research output: Contribution to journalReview articlepeer-review

17 Scopus citations


Endophthalmitis remains a rare but serious cause of visual loss. Over time, changes have been noted in endophthalmitis in terms of predominant causes, infecting organisms and antibiotic susceptibilities. There is controversy regarding the use of intracameral prophylactic antimicrobials during cataract surgery. Alternatively, there appears to be increasing evidence against using routine topical antibiotics for intravitreal injections. There are also increasing reports of multidrug-resistant organisms causing endophthalmitis, but the combination of vancomycin and ceftazidime appears effective for the vast majority of cases. Future trends may involve increasing utilization of polymerase chain reaction for diagnosis, and possibly office-based pars plana vitrectomy for treatment of endophthalmitis.

Original languageEnglish (US)
Pages (from-to)425-430
Number of pages6
JournalExpert Review of Ophthalmology
Issue number5
StatePublished - Oct 1 2014


  • antibiotics
  • endophthalmitis
  • intravitreal injection
  • pars plana vitrectomy
  • polymerase chain reaction

ASJC Scopus subject areas

  • Ophthalmology
  • Biomedical Engineering
  • Optometry


Dive into the research topics of 'Update on the prevention and treatment of endophthalmitis'. Together they form a unique fingerprint.

Cite this